APA

Thompson D. S., Greco A., Miller A. A., Srinivas N. R., Igwenezue K. B., Hainsworth J. D., Schacter L. P., Kaul S., Barbhaiya R. H. & Garrow C. (19950630). A phase I study of etoposide phosphate administered as a daily 30-minute infusion for 5 days. : Clinical pharmacology and therapeutics.

Chicago

Thompson D S, Greco A, Miller A A, Srinivas N R, Igwenezue K B, Hainsworth J D, Schacter L P, Kaul S, Barbhaiya R H and Garrow C. 19950630. A phase I study of etoposide phosphate administered as a daily 30-minute infusion for 5 days. : Clinical pharmacology and therapeutics.

Harvard

Thompson D. S., Greco A., Miller A. A., Srinivas N. R., Igwenezue K. B., Hainsworth J. D., Schacter L. P., Kaul S., Barbhaiya R. H. and Garrow C. (19950630). A phase I study of etoposide phosphate administered as a daily 30-minute infusion for 5 days. : Clinical pharmacology and therapeutics.

MLA

Thompson D S, Greco A, Miller A A, Srinivas N R, Igwenezue K B, Hainsworth J D, Schacter L P, Kaul S, Barbhaiya R H and Garrow C. A phase I study of etoposide phosphate administered as a daily 30-minute infusion for 5 days. : Clinical pharmacology and therapeutics. 19950630.